South Korea
· Delayed Price · Currency is KRW TegoScience Statistics
Total Valuation
TegoScience has a market cap or net worth of KRW 124.10 billion. The enterprise value is 97.97 billion.
| Market Cap | 124.10B |
| Enterprise Value | 97.97B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TegoScience has 8.01 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Shares Outstanding | 8.01M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 42.46% |
| Owned by Institutions (%) | 0.14% |
| Float | 4.60M |
Valuation Ratios
The trailing PE ratio is 37.00.
| PE Ratio | 37.00 |
| Forward PE | n/a |
| PS Ratio | 17.79 |
| PB Ratio | 2.44 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.22 |
| EV / Sales | 14.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -139.54 |
Financial Position
The company has a current ratio of 15.59, with a Debt / Equity ratio of 3.25.
| Current Ratio | 15.59 |
| Quick Ratio | 14.84 |
| Debt / Equity | 3.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.35 |
| Interest Coverage | -20.96 |
Financial Efficiency
Return on equity (ROE) is 6.80% and return on invested capital (ROIC) is -2.01%.
| Return on Equity (ROE) | 6.80% |
| Return on Assets (ROA) | -1.97% |
| Return on Capital (ROIC) | -2.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +69.05% |
| 50-Day Moving Average | 18,104.40 |
| 200-Day Moving Average | 16,904.60 |
| Relative Strength Index (RSI) | 38.45 |
| Average Volume (20 Days) | 15,678 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TegoScience had revenue of KRW 6.97 billion and earned 3.35 billion in profits. Earnings per share was 418.88.
| Revenue | 6.97B |
| Gross Profit | 4.68B |
| Operating Income | -1.63B |
| Pretax Income | 3.05B |
| Net Income | 3.35B |
| EBITDA | -1.09B |
| EBIT | -1.63B |
| Earnings Per Share (EPS) | 418.88 |
Balance Sheet
The company has 27.73 billion in cash and 1.65 billion in debt, giving a net cash position of 26.08 billion or 3,256.91 per share.
| Cash & Cash Equivalents | 27.73B |
| Total Debt | 1.65B |
| Net Cash | 26.08B |
| Net Cash Per Share | 3,256.91 |
| Equity (Book Value) | 50.73B |
| Book Value Per Share | 6,343.07 |
| Working Capital | 30.27B |
Cash Flow
In the last 12 months, operating cash flow was -695.75 million and capital expenditures -6.34 million, giving a free cash flow of -702.10 million.
| Operating Cash Flow | -695.75M |
| Capital Expenditures | -6.34M |
| Free Cash Flow | -702.10M |
| FCF Per Share | -87.69 |
Margins
Gross margin is 67.17%, with operating and profit margins of -23.37% and 48.07%.
| Gross Margin | 67.17% |
| Operating Margin | -23.37% |
| Pretax Margin | 43.69% |
| Profit Margin | 48.07% |
| EBITDA Margin | -15.64% |
| EBIT Margin | -23.37% |
| FCF Margin | -10.07% |
Dividends & Yields
TegoScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | -0.96% |
| Earnings Yield | 2.70% |
| FCF Yield | -0.57% |
Stock Splits
The last stock split was on July 11, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jul 11, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |